Condition: Arthroplasty Replacement, Knee · Arthroplasty Total Hip Replacement · Sponsor: Solventum US LLC
The goal of this clinical study is to generate data on the intended use of a chlorhexidine gluconate (CHG)-impregnated antimicrobial incise drape. The study includes subjects undergoing primary hip or knee arthroplasty procedures. The study evaluates the intraoperative performance and safety of the incise drape during surgery, including assessment of contamination and operative characteristics. Participants will have a CHG-impregnated antimicrobial incise drape applied during their surgical procedure. During surgery, samples will be collected from the operative site to assess potential bacterial contamination.
This description comes directly from the study's public registry record.
Tracy E Swanson · 6125417752 · tswanson@solventum.com
Stephanie Karwedsky · 6124272830 · skarwedsky@solventum.com
Always discuss trial participation with your own doctor first.
| Indiana University Health (IU Health) | Fishers, Indiana, United States | Recruiting |
| University of Utah Health - Department of Orthopedics | Salt Lake City, Utah, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07356323